All In Biotech

Drug Trial Radar · NCT07533942

A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma

A Phase 2 Study to Investigate Efficacy, Safety, Tolerability, and Pharmacokinetics of JZP3507 (ONC206) in Adults With Recurrent Grade 2 or 3 Meningioma

Last checked: Nov 19, 2026Latest source record: Oct 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

30

Planned (sponsor's estimate)

Start

Jul 16, 2026

Primary completion

Oct 25, 2028

Study completion Oct 16, 2031

Sponsor

Lead sponsor
Jazz PharmaceuticalsJazz Pharmaceuticals (JAZZ)
Sponsor type
Industry
Collaborators
Chimerix, Inc.
First posted
Apr 16, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will recruit participants with Grade 2 and 3 meningiomas who have failed prior therapy. Participants will receive oral doses of JZP3507. The antitumor activity and safety of JZP3507 will be evaluated.

Conditions

  • Meningioma

Interventions

  • JZP3507Drug

    Participants will receive oral JZP3507 monotherapy twice daily, on 3 consecutive days per week in 28-day cycles.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall Response Rate (ORR) as Assessed by Response Assessment in Neuro-Oncology (RANO) Criteria and Evaluated by Blinded Independent Central Review (BICR)Time frame: From first dose until death, withdrawal of consent, or lost to follow-up, up to 36 months.

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • Sutter Health

    San Francisco, California · Recruiting

  • Yale-New Haven Hospital - Yale Cancer Center

    New Haven, Connecticut · Recruiting

  • Indiana University Health Neurosurgery Clinic

    Indianapolis, Indiana · Recruiting

  • Louisiana State University

    New Orleans, Louisiana · Recruiting

  • Mass General

    Boston, Massachusetts · Not yet recruiting

  • NYU- Langone Health

    New York, New York · Recruiting

  • Duke University Medical Center

    Durham, North Carolina · Recruiting

  • University of Utah - Huntsman Cancer Institute

    Salt Lake City, Utah · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.